Questioning Medicine
Episode 257: 256. EMPEROR-Reduced- Cardiovascular Outcomes with Empagliflozin in Heart Failure
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:09:48
- Mais informações
Informações:
Sinopse
NNT of 20 to prevent 1 hospitalization at 16 months of follow upThey composite outcome was driven by decrease hospitalizations NOT deathhttps://www.nejm.org/doi/full/10.1056/NEJMoa2022190
